Mariastella Zannini
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far.
Journal: OncoTargets and therapy
Published: June 30, 2022
PAX8, an Emerging Player in Ovarian Cancer.
Journal: Advances in experimental medicine and biology
Published: August 02, 2021
Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
Journal: International journal of molecular sciences
Published: May 05, 2020
PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3.
Journal: Cancer cell international
Published: April 02, 2019
Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses.
Journal: International journal of genomics
Published: May 12, 2017
The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses.
Journal: The Journal of biological chemistry
Published: December 29, 2016
Erratum to: In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1.
Journal: BMC developmental biology
Published: August 17, 2016
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
Journal: Oncotarget
Published: March 24, 2016
NF-κB Essential Modulator (NEMO) Is Critical for Thyroid Function.
Journal: The Journal of biological chemistry
Published: January 05, 2016
Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells.
Journal: PloS one
Published: February 10, 2015
Last Updated: 09/26/2026